Print Page  Close Window

SEC Filings

SC 13G/A
BIOTECHNOLOGY VALUE FUND L P filed this Form SC 13G/A on 02/14/2017
Entire Document
 
11

 
CUSIP NO. 92847N 10 3

SIGNATURE

After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated:  February 14, 2017
 
BIOTECHNOLOGY VALUE FUND, L.P.
     
 
 
   
BVF INC.
By:
BVF Partners L.P., its general partner
   
 
By:
BVF Inc., its general partner
 
By:
/s/ Mark N. Lampert
 
 
   
Mark N. Lampert
By:
/s/ Mark N. Lampert
   
President
 
Mark N. Lampert
     
 
President
   
 
 
 
   
/s/ Mark N. Lampert
 
 
   
MARK N. LAMPERT
BIOTECHNOLOGY VALUE FUND II, L.P.
   
 
 
     
By:
BVF Partners L.P., its general partner
     
By:
BVF Inc., its general partner
     
 
 
     
By:
/s/ Mark N. Lampert
     
 
Mark N. Lampert
     
 
President
     
         
       
         
BVF PARTNERS L.P.
     
         
By:
BVF Inc., its general partner
     
 
 
     
By:
/s/ Mark N. Lampert
     
 
Mark N. Lampert
     
 
President
     

 
BVF PARTNERS OS LTD.
   
By:
BVF Partners L.P., its sole member
By:
BVF Inc., its general partner
 
 
By:
/s/ Mark N. Lampert
 
Mark N. Lampert
 
President
   
   
BIOTECHNOLOGY VALUE TRADING FUND OS LP
   
By:
BVF Partners L.P., its investment manager
By:
BVF Inc., its general partner
 
 
By:
/s/ Mark N. Lampert
 
Mark N. Lampert
 
President